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Cells and organisms must coordinate their metabolic activity with changes in their environ-
ment to ensure their growth only when conditions are favourable. In order to maintain cellular
homoeostasis, a tight regulation between the synthesis and degradation of cellular compo-
nents is essential. At the epicentre of the cellular nutrient sensing is the mechanistic target
of rapamycin complex 1 (mTORC1) which connects environmental cues, including nutrient
and growth factor availability as well as stress, to metabolic processes in order to preserve
cellular homoeostasis. Under nutrient-rich conditions mTORC1 promotes cell growth by
stimulating biosynthetic pathways, including synthesis of proteins, lipids and nucleotides,
and by inhibiting cellular catabolism through repression of the autophagic pathway. Its close
signalling interplay with the energy sensor AMP-activated protein kinase (AMPK) dictates
whether the cell actively favours anabolic or catabolic processes. Underlining the role of
mTORC1 in the coordination of cellular metabolism, its deregulation is linked to numerous
human diseases ranging frommetabolic disorders to many cancers. Although mTORC1 can
be modulated by a number of different inputs, amino acids represent primordial cues that
cannot be compensated for by any other stimuli. The understanding of how amino acids sig-
nal to mTORC1 has increased considerably in the last years; however this area of research
remains a hot topic in biomedical sciences. The current ideas and models proposed to ex-
plain the interrelationship between amino acid sensing, mTORC1 signalling and autophagy
is the subject of the present review.
Introduction
Sensing of the environment is essential for cells and organisms to coordinate their metabolic activity. Nu-
trients, growth factors and cellular energy trigger biosynthetic pathways and thereby stimulate growth.
However, in response to nutrient limitation and other cellular stresses, cells induce a variety of responses
that enable them to survive upon unfavourable conditions. Central amongst these is macroautophagy
(hereinafter referred to as autophagy), a major intracellular degradation pathway that supports cell sur-
vival by eliminating damaged and potentially harmful cellular structures, and sustains energy homoeosta-
sis during starvation by recycling of cytosolic components to compensate for nutrient deprivation [1].
The convergence point of anabolic and catabolic processes is the mechanistic target of rapamycin
(mTOR),which senses fluctuations in extracellular and intracellular nutrients tomodulate cellular growth,
metabolism and survival. mTOR is an evolutionarily conserved serine/threonine protein kinase that be-
longs to the PI3K-related kinase (PI3KK) superfamily. This atypical kinase nucleates two structurally and
functionally different complexes termed mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)
[2]. In addition to themTORcatalytic subunit,mTORC1 consists of regulatory-associatedprotein ofmam-
malian target of rapamycin (Raptor) (a scaffold protein that is required for the correct subcellular local-
ization of mTORC1) [3,4], mammalian lethal with Sec13 protein 8 (mLST8, also known as GßL) (which
associates with the catalytic domain of mTOR and stabilizes the kinase activation loop) [3-6], and the two
inhibitory subunits proline-rich Akt substrate of 40 kDa (PRAS40) [7-10] and DEP domain containing
MTOR-interacting protein (DEPTOR) [11]. mTORC2 shares some components with mTORC1 includ-
ing the core kinase protein mTOR as well as mLST8/GβL and DEPTOR. However, instead of Raptor,
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Figure 1. mTORC1 signalling links cellular growth with autophagy
A range of physiological signals affects the activation status of mTORC1, including growth factor signalling, cellular energy levels
via AMP-activated kinase (AMPK), oxygen levels and nutrients, particularly amino acids. The activation of mTORC1 regulates a
number of cellular processes that affect the metabolic state of the cell. Through different mechanisms, mTORC1 signalling in-
hibits autophagy while promoting cell growth by stimulating biosynthetic pathways, including the synthesis of proteins, lipids and
nucleotides.
mTORC2 contains rapamycin-insensitive companion of mTOR (Rictor) and the regulatory subunits Sin1 [12-14]
and Protor 1/2 [15,16]. mTORC1 and mTORC2 can be distinguished on the basis of their sensitivity to rapamycin
which only inhibitsmTORC1 [17]. The two complexes are responsive to different signals and produce different down-
stream outputs. While mTORC2 regulates cytoskeleton organization and cell survival [18,19], the major cellular role
of mTORC1 is the control of cell growth. mTORC1 senses and responds to fluctuations in the levels of intra- and ex-
tracellular nutrients, primarily amino acids as well as growth factor signalling, cellular energy (via AMP-dependent
kinase, AMPK) and oxygen levels. When active, mTORC1 promotes anabolic processes such as protein, lipid and
nucleotide synthesis through phosphorylation of its downstream effectors ribosomal protein S6 kinase (S6K) and
eukaryotic translation initiation factor 4E-binding protein (4E-BP) thus inducing cell growth and proliferation. At
the same time it represses catabolic programmes via unc-51-like autophagy activating kinase 1 (ULK1), thus lead-
ing to the inhibition of autophagy. However, upon stress conditions (including amino acid deprivation) mTORC1
inactivation stimulates the formation of the ULK1-containing pro-autophagic complex, which ultimately entails the
formation of autophagosomes [20-22] (Figure 1).
A master activator of mTORC1 kinase activity is the small GTPase Rheb (Ras-homologue enriched in brain)
[23,24]. This GTPase has a C-terminal CaaX domain that is a subject to farnesylation which defines its subcellu-
lar localization in association with endomembranes, most importantly lysosomes [25,26]. The GTP-loaded Rheb
interacts with the mTOR catalytic domain and activates mTORC1 [27]. To date, the regulators of GTP loading onto
Rheb as well as the precise mechanism via which Rheb activates mTORC1 have yet to be discovered [28]. How-
ever, Rheb is negatively controlled by a heterotrimeric complex consisting of tuberous sclerosis complex 1 (TSC1),
TSC2 and TRE2–BUB2–CDC16 domain family member 7 (TBC1D7) [29-31]. Specifically, the TSC2 subunit acts as
a GTPase-activating protein (GAP) towards Rheb and promotes the hydrolysis of Rheb-bound GTP, thus converting
Rheb to GDP-bound inactive form, which subsequently inhibits mTORC1 [23,24,29,32,33]. The TSC complex has
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emerged as a hub for numerous incoming cellular signals to regulate mTORC1 activity ranging from growth fac-
tor signalling, hypoxia, DNA damage or energy status [34,35]. Amongst them, PI3K/Akt (activated in the presence
of growth factors), AMPK (which is activated in response to energy or glucose deprivation), the hypoxia-induced
REDD1 (regulated in development and DNA damage responses 1), Erk (extracellular-signal-regulated kinase) [36]
or GSK-3β (glycogen synthase-3β), all of which regulate TSC2 activity [34]. Despite the importance of the TSC com-
plex in mTORC1 activity modulation, not all the inputs into mTORC1 signalling impinge directly on the control of
the axis TSC2–Rheb. Indeed, amino acids, which are necessary and sufficient for the basal activation of mTORC1,
can modulate mTORC1 activity via different mechanisms.
Amino acids and mTORC1
Amino acids are fundamental nutrients that serve as building blocks for protein synthesis and cell growth. They are
importantmetabolic intermediates that contribute tomultiple cellular functions. Indeed, the availability of intracellu-
lar amino acids is essential to promote anabolic processes in the cell, including energy production, mRNA translation
and, subsequently, cell growth and proliferation. When amino acids are scarce, protein synthesis is switched off and
catabolic processes are triggered in order to generate amino acid sufficiency and restore cell function [37,38]. Thus,
amino acids are both necessary and sufficient to have an impact on cellular metabolism with important implications
for mTORC1 activity and autophagy regulation. Signalling via mTORC1 regulates expression of genes involved in
glycolysis, pentose phosphate pathway, lipid biogenesis and pyrimidine biosynthesis [39,40]. Both influx of nutrients
from the extracellular environment and recycling of intracellular resources regulate intracellular levels of amino acids
to ensure the availability of free amino acids at an appropriate concentration for promoting anabolic processes in the
cells. Cellular demands for amino acids are cell- and tissue-specific; while glutamine is an important energy source
feeding the tricarboxylic acid (TCA) cycle particularly in glycolysis-dependent tumour cells [41], arginine influx and
arginase levels are tightly regulated in liver for the urea cycle [42].
Leucine, glutamine and arginine have been widely shown as the main contributors to mTORC1 activation [43-47].
In particular, glutamine, in addition to serving as a key energy source, cooperates with leucine to activate mTORC1.
Glutamine can be deaminated to produce α-ketoglutarate, which is both an intermediate in the TCA cycle and a
regulator of mTORC1 activity and autophagy. However, this reaction requires the presence of leucine, which acts as
a cofactor of the enzyme that catalyses the last step of glutaminolysis [48].
The mechanisms via which amino acids can influence mTORC1 are still only partially elucidated but the existing
body of data suggests a highly complex control of amino acid sensing as described in the following sections.
Lysosome as a hub of amino acid sensing
The first indication that amino acids play an essential role in the regulation of mTORC1 and that this signalling is
connected to the regulation of autophagy was shown in a study of hepatocyte autophagy. Bloomaart and colleagues
observed that, addition of amino acids inhibited autophagic proteolysis and this inhibition was correlated with the
stimulation of S6 phosphorylation [49]. In addition, rapamycin treatment inhibited the effect of amino acids. This
study was supported by the subsequent observation that treatment of the cells with protein translation inhibitors,
which increase the pool of intracellular amino acids, activates mTORC1 and inhibits autophagy even in starvation
conditions [50,51]. Nevertheless, the mechanism by which amino acids stimulate mTORC1 activity and inhibit au-
tophagy andwhether all amino acids or amino acids byproducts are sensed are still to some extent, an enigma. Leucine,
glutamine and arginine have beenwell documented as themost importantmediators inmTORC1 activation;however,
no individual amino acid is sufficient for its activation in cells deprived of the remaining amino acids and therefore
autophagy inhibition.
A key breakthrough in the understanding of the subcellular control of mTORC1 by amino acids was the finding
that amino acids are able to regulate the intracellular localization of mTORC1 [26,52]. Specifically, upon amino acid
withdrawal mTORC1 can be found diffuse throughout the cytoplasm, while replenishment of amino acids rapidly
translocates mTORC1 to the surface of vesicles positive for Rab7 and LAMP2 (lysosome-associated membrane pro-
tein 2) [52], both markers for late endosomes and lysosomes. These observations suggested that amino acids may
stimulate mTORC1 activity by translocating it to the lysosomal surface where it is presumed to interact with the
small GTPase Rheb [26]. Subsequent studies have shown the scaffold protein Raptor as the mediator in the localiza-
tion of the complex to the lysosome [52]. Tethering of mTORC1 to the lysosomal membrane is fundamental in the
modulation of Rheb/TSC-mediated mTORC1 activation, thus providing a mechanism that explains why activation
of mTORC1 by growth factors requires the presence of amino acids. These observations also identify the lysosome
as a hub controlling mTORC1 activity. However, the fact that leucine can regulate mTORC1 activity independent of
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its effect on the lysosomal localization of mTOR illustrates an important distinction between the signals exerted by
a single amino acid which strongly regulates mTORC1 and by a mixture of other amino acids [53]. These findings
also establish that the sensing of leucine and the activation of mTORC1 have to be considered as complex processes
which likely involve additional compartments besides the lysosome. Although Rheb is essential for amino acids to
activate mTORC1, the primary amino acid sensing pathway appears to function in parallel to Rheb but involves a
separate set of small GTPases, the Rag GTPases [26,54]. The Rag GTPases are members of the Ras superfamily of Rag
GTPases and drive the recruitment and retention of mTORC1 to the lysosome upon amino acid availability [52]. The
Rag GTPases are stably anchored to lysosomal membranes and act as docking sites for mTORC1 at this organelle by
directly binding Raptor. Four members of this family have been described in mammals: RagA and RagB (RagA/B),
which are highly homologous and functionally redundant, and RagC and RagD (RagC/D), which have also high se-
quence similarity and are functionally equivalent. RagA/B binds to RagC/D to form heterodimeric complexes and
this dimerization is important for Rag protein stability but also essential for mTORC1 activation [26,54]. The as-
sociation between mTORC1 and Rag GTPases is highly dependent on the guanine-nucleotide binding state of the
heterodimer, with mTORC1 binding predominantly to heterodimers consisting of RagA/B · GTP and RagC/D · GDP.
Amino acid sufficiency promotes the accumulation of RagA/B · GTP–RagC/D · GDP, allowing them to bind Raptor
and recruit mTORC1 to the lysosomal surface, where it binds Rheb to form an active holoenzyme [52]. However, the
absence of amino acids switches the Rag heterodimer into an inactive conformation containing GDP-bound RagA/B,
thereby, releasing mTORC1 from the lysosomes [55,56]. This regulatory role of the Rags has been shown to be con-
served in mice [57], flies [54] and yeasts [58]. Indeed, in both mammalian and Drosophila cells, overexpression of
GTP-boundmutants of RagA or RagB rendersmTORC1 constitutively active and insensitive to amino acid starvation
[26,54]. As the amino acid-dependent mTORC1 signalling appears to be regulated by GTP/GDP charging of the Rag
heterodimers, the study of the mechanisms that communicate amino acid availability to the Rag GTPases and the
proteins involved in the modulation of their nucleotide-binding status has become of particular interest in the un-
covering of amino acid sensing. Indeed, several guanine nucleotide exchange factors (GEFs) and GAPs that regulate
the nucleotide status of the Rag GTPases have already been identified, with themost notable GEF being the Ragulator
complex [52,59] and with GAPs including the GAP activity towards the Rags (GATOR) 1 complex (towards RagA/B)
[55], the tumour suppressor folliculin (FLCN) in complex with FLCN-interacting protein 1/2 (towards RagC/D) [60]
and leucyl tRNA synthetase (towards RagD) [44,61]. Furthermore, an arsenal of additional proteins has recently been
identified as regulators of the Rag GTPases. Together, these proteins cooperate to ensure the right conformation of
the Rag GTPases to promote mTORC1 localization and activity.
Ragulator, a GEF for RagA/B
The multi-protein complex called Ragulator or late endosomal/lysosomal adaptor, MAPK and mTOR activator 1
(LAMTOR), has been shown responsible for both the regulation of the nucleotide-binding state of the Rag GTPases
and their subcellular localization [52,59] since the Rag proteins do not contain lipid modifications to anchor them to
the lysosomal membrane. The Ragulator complex comprises p18 [encoded by LAMTOR1 (late endosomal/lysosomal
adaptor, MAPK and mTOR activator)], p14 (encoded by LAMTOR 2), MP1 (MEK-binding partner 1, encoded by
LAMTOR 3), C7orf59 (encoded by LAMTOR 4) and HBXIP (hepatitis B virus X-interacting protein, encoded by
LAMTOR 5). Amongst its components, LAMTOR 1 functions as a scaffold for the Rag GTPases and the two het-
erodimers LAMTOR2/LAMTOR3 and LAMTOR4/LAMTOR5 anchoring the complex to the lysosomal surface via
dual N-terminal lipid modifications (myristoylation and palmitoylation) [62]. Although Ragulator orthologues have
not been identified in yeast, a recent study unveils the ternary complex EGO 1–3 analogously localizing GTRs and
TORC1 at the vacuolar surface [63]. Depletion of Ragulator components disrupts Rag GTPases attaching to the lyso-
some and preventsmTOR shuttling to its surface [52,59]. As discussed above, Ragulator is required for the localization
of the Rag heterodimer to the lysosomal membranes and acts as a GEF towards RagA/B, promoting the exchange of
GDP for GTP and consequent activation of the Rag complex and lysosomal recruitment of mTORC1 [59]. The GEF
activity of the Ragulator complex appears to be restricted to RagA/B, not displaying any activity towards RagC/D or
other GTPases [59] and all the components of the complex are essential for its GEF activity and thus, for amino acid
sensing to mTORC1.
GATOR complex, a GAP for RagA/B
GATOR is a multi-protein complex composed of two subcomplexes, GATOR1 and GATOR2, localized at the lysoso-
mal membrane [55,56]. GATOR1 contains three proteins, DEP domain containing 5 (DEPDC5), nitrogen permease
regulator 2-like protein (NPRL2) and NPRL3, whereas GATOR2 is composed of five components MIOS, WDR24,
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WDR59, SEH1L and SEC13. Of these two complexes, only GATOR1 interacts directly with RagA/B acting as a GAP
thus leading to its deactivation and subsequently suppression of mTORC1 activity [55,56]. A recent study has char-
acterized the multi-protein complex KICSTOR responsible for targeting GATOR1 to the lysosomal surface [64].
GATOR2 negatively regulates GATOR1 and relieves mTORC1 from its inhibition, thus rendering mTORC1 unre-
sponsive to amino acids [55,56]. The inhibitory effect of GATOR2 on GATOR1 is mediated by Sestrin proteins (see
below); however, how GATOR2 mediates its inhibiting effect and how amino acids regulate the complex is not fully
settled.
SH3BP4, a GAP for RagB
SH3 (Src-homology 3 domain)-binding protein 4 (SH3BP4) was found to reduce mTORC1 signalling by increasing
both RagB GTP hydrolysis and preventing RagB GDP dissociation [65]. Its effect on mTORC1 signalling is more
similar to that of a modulator.
FLCN and LRS: GAPs for RagC/D
Folliculin (FLCN) is a GAP that activates mTORC1 by specifically regulating the nucleotide status of RagC/D. Its
binding to the lysosome further requires association with the FLCN interacting proteins 1 and 2 (FNIP1 and 2)
[60,66]. In vitro studies established that FLCN localizes to the lysosome upon amino acid starvation and only when
RagA/B is GDP-loaded. GTP loading of RagA/B in the presence of amino acids stimulates the GAP activity of FLCN
towards RagC/D and liberates FLCN from the lysosome [60].
The enzyme responsible for loading tRNAwith leucine, leucyl tRNAsynthetase (LRS), has been reported as a posi-
tive regulator of mTORC1 activity by acting as a GAP for RagD [44,61]. LRS was found to translocate to the lysosome
and bind Rag GTPases in a leucine-dependent manner where it acts as a GAP to promote the GTPase activity of
RagD, required for mTORC1 activity [44]. However, in a subsequent study, the GAP activity of purified LRS towards
RagD could not be reproduced [60] and the relevance of LRS to leucine sensing by mTORC1 remains to be validated.
RNF152 and SKP2, E3 ubiquitin ligases for RagA
It has recently been reported that the ubiquitination of RagA by two independent E3 ubiquitin ligases, RNF152 [67]
and SKP2 [68], negatively regulates mTORC1 activation. These studies revealed that targeting RagA for ubiquitina-
tion increases the interaction of RagA and GATOR1. Furthermore, overexpression of RagA ubiquitination-deficient
mutant reduces RagA–GATOR1 interaction and thus increases mTORC1 activity. Deng et al. showed that amino
acid withdrawal increases the RNF152–RagA interaction and, consequently, RagA ubiquitination [67]. However, Jin
et al. proposed that amino acids promote SKP2-mediated RagA interaction with GATOR1, which is inconsistent with
previous studies showing that amino acid starvation increases the interaction between RagA and GATOR1 [68]. To
explain this controversial observation they propose a negative feedback mechanism whereby SKP2-mediated RagA
ubiquitination recruits GATOR1 to restrict mTORC1 signalling upon sustained amino acid stimulation, which serves
to maintain proper cellular functions.
Mechanisms of amino acid sensing
The findings described above identify the molecular platform necessary for mTORC1 activation at the lysosomal
surface and have helped in the understanding of the amino acid-dependent Rag-mediated regulation. However, in-
creasing evidence suggests other pathways to positively regulate mTORC1 in response to amino acids. Indeed, it is
now clear that mTORC1 senses both, intralysosomal and cytosolic amino acids through distinct mechanisms (Figure
2). All these mechanisms cooperate to provide a sensory readout from more than one subcellular compartment with
varying sensitivity to amino acids, thus leading to the tight control of the metabolic state.
Lysosomal amino acid sensing
The identification of the lysosomal proton pump, the v-ATPase, as part of the lysosomal mTORC1 supercomplex, led
to propose a mechanism of amino acid sensing where the v-ATPase acts as a sensor [69]. In addition to its role in pro-
ton pumping inside the lysosome, the v-ATPase responds to an increase in the intralysosomal, rather than cytosolic,
amino acid concentration with a conformational change that weakens its binding with Ragulator [69]. These amino
acid-sensitive interactions are required for proper nucleotide loading of the Rag GTPases, recruitment of mTORC1 to
the lysosome and, thereby, activation of mTORC1 [69]. These observations led Sabatini and colleagues to propose the
lysosome-centric “inside–out” model of amino acid sensing in which amino acids must accumulate in the lysosomal
lumen to initiate signalling and the v-ATPase may act as a sensor [69].
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Figure 2. Models of amino acid-dependent mTORC1 regulation
The presence of free amino acids is essential for the activation of mTORC1. Leucine, glutamine and arginine signal to mTORC1
by different mechanisms. These include cytoplasmic sensors, amino acid transporters and v-ATPase on the lysosomal membrane.
The amino acid transporters sense specific amino acids in different subcellular compartments and act in cooperation with cytosolic
amino acid sensors to control the activity of mTORC1. Other transporters act as conduits bringing amino acids inside the cell. All
these mechanisms work to control the nucleotide-loading status of either Rag GTPases or Rheb, the most proximal regulators of
mTORC1. mTORC1 hubs controlled by Arf1 and Rab1A/PAT4 appear to be Rag independent and are therefore not under the control
of the cytosolic sensors. Arf1 is typically found on Golgi membranes but is reported to control a lysosomal sensing complex.
However, the precise mechanism by which the v-ATPase signals amino acid sufficiency still remains to be deter-
mined; particularly the role of the ATPase activity for mTORC1 activation is not well understood. While chemical
inhibition of ATP hydrolysis activity rendersmTORC1 inhibition [69], other study has shown that the ATPase activity
increases upon amino acid withdrawal [70]. Specifically, amino acid deprivation may drive conformational changes
in the v-ATPase [69], potentially increasing its assembly [70] and consequently enhancing its interaction with the Rag
GTPases–Ragulator complex.Moreover, others have demonstrated that intraluminal pH of the lysosome is important
to support mTORC1 activity [71].
It also remains unclear whether amino acid sensing via the lysosomal lumen involves the direct trafficking of amino
acids from the cytoplasm into the lysosome or whether the amino acids sensed here are generated as a consequence
of the degradative process in the lysosome. Amino acid transport and accumulation within the lysosomal lumen do
not appear to be driven by a proton gradient, as shown by freely diffusible alcohol ester derivatives of amino acids
which enter the lysosome regardless of the v-ATPase activity [69,72]. Overexpression of the proton-assisted amino
acid transporter (PAT) 1, which exports amino acids from the lysosome, inhibits mTORC1 activation [69], likely due
to the leak of amino acids from the lysosome.However, these results require careful interpretation as overexpression of
PAT1 can either promote growth and mTORC1 signalling in vivo and in cell culture [73,74] or inhibit these processes
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when expression levels are raised further, potentially via a dominant negative mechanism [69,73]. These observations
indicate the importance of a careful balance in amino acid distribution or transport for proper mTORC1 activity.
Lysosomal localization of amino acid transporters led to a model in which amino acid sensing is carried out by
these transporters based on their ability to bind amino acids from the lysosomal lumen and export them to the cy-
tosol [75,76]. However, it is still unknown whether this system allows to sense specific, individual amino acids or
overall concentration of amino acids. To date, the only transporter implicated in sensing of a specific amino acid
from within the lysosome is the sodium-coupled amino acid transporter SLC38A9, which participates in sensing
arginine following starvation and refeeding [77]. This observation is of particular interest since this transporter has
higher affinity for other amino acids such as glutamine [78]. SLC38A9 has been identified as a physical and func-
tional component of the Rag–Ragulator complex in lysosomes [77-79]. Its overexpression caused sustained mTORC1
activation even during amino acid starvation, while mTORC1 activation was abolished in SLC38A9 knockout cells
[79]. Interestingly, knockdown of SLC38A9 prevents starvation-induced relocalization of mTOR to the cytoplasm
[79]; however, the mechanism of mTOR retention is unknown.
PAT1, a member of the PAT or SLC36 family broadly expressed in humans, was shown to be required for amino
acid-dependent mTORC1 activation and cell proliferation in embryonic kidney and breast cancer cells [74]. Inter-
estingly, PAT1, as well as other members of this family, has been shown to transport alanine, glycine and proline
[80,81], which are not potent mTORC1 activators, so it is not necessarily clear exactly how these transporters may
influencemTORC1. PAT1 is concentrated at the surface of late endosomes and lysosomes inmany cell types, wherein
it forms a complex with Rag GTPases and has been suggested to mediate the regulation of amino acid-dependent
mTORC1 localization [82]. Interestingly, this study highlights the cooperation of growth factors and amino acids in
mTORC1 regulation, since PI3K/Akt/Rheb signalling increases lysosomal localization of PAT1 which would facilitate
mTORC1 activation [82]. A recent work reports that accumulation of PAT1 in the lysosomal surface can be prevented
by FLCN. Specifically, elevated FLCN levels lead to the decrease in PAT1 localization to the lysosome thus enabling
cells to sequester amino acids such as leucine within the lysosome and activate mTORC1 even under amino acid
starvation conditions [83]. This is an interesting concept, as FLCN is normally accumulated in the lysosome upon
amino acid starvation. However, one explanation is that endogenous levels of FLCN are not sufficient to affect PAT1
and intracellular amino acid levels, and thus, mTORC1 is switched off [66].
The above-mentioned lysosomal amino acid transporters provide an arguably logical explanation that amino acids
exported from the lysosome to the cytoplasmwould be sensed bymTORC1, though the precisemechanism via which
these transporters contribute to mTORC1 activation and autophagy suppression is still unclear. One interesting av-
enue is the concept of a dual-function amino acid transporter/receptor, which proposes that they can act as tran-
sceptors, functioning via sensing and signalling amino acid availability rather than their transport [73,84]. This may
also help to explain the potent effect of PAT1 in cellular growth when it transports amino acids that are not potent
mTORC1 activators [80,81] and why SLC38A9 senses arginine when it has higher affinity for glutamine [85].
Understanding how the transport of lysosomal amino acids is orchestrated is an area of significant interest for fu-
ture research. Perhaps, the most straightforward explanation for the apparent complexity of the molecular machinery
involved in this processes is that both lysosomal amino acid transporters and the v-ATPase cooperate to ensure tight
control of the amino acid sensing at the lysosome. Supporting this idea, v-ATPase inhibition inHEK293T cells overex-
pressing SLC38A9 does not inhibit mTORC1 signalling upon amino acid deprivation, though inhibition of v-ATPase
activity in cells not overexpressing SLC38A9 inhibits mTORC1 activation in response to amino acid stimulation [78].
Another recent study argues that the coupling of v-ATPase and PAT1 could explain why the reduction in the pro-
ton gradient across the lysosomal surface does not block amino acid-dependent mTORC1 relocalization [82]. The
authors propose a model where PAT/Rag/Ragulator–v-ATPase complex is required to establish a microenvironment
for cycling of protons and export of amino acids that is needed to drive amino acid sensing at the lysosome [82].
It is also of interest that the mechanisms that target amino acids to the lysosomes are largely unknown. To date,
only one functional amino acid transporter, the heterodimeric transporter SLC7A5 (LAT1)/SLC3A2 that couples
the import of leucine with the simultaneous efflux of L-glutamine and stimulates mTORC1 activation via v-ATPase,
has been identified at the lysosome. SLC7A5/SLC3A2 is recruited to the lysosomal membrane via a protein called
LAPTM4b [86].
The lysosomal lumen environment, therefore, provides a complex readout of amino acid levels for mTORC1 and
uncovering further mechanisms that regulate their sensing will greatly enhance our understanding of this signal
transduction pathway.
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Cytosolic amino acid sensing
Although it has been well documented that lysosomes are essential organelles for amino acid sensing, increasing evi-
dence suggest that they can also signal to mTORC1 from the cytoplasm. Especially, some of the main contributors to
mTORC1 activation, such as leucine, glutamine and arginine [43-45,87,88], are also sensed outside the lysosome. Cy-
toplasmic sensors of leucine and arginine have been recently identified. Sestrin (SESN) 2, which has long been known
to influence cellular growth andmetabolism, acts as a direct leucine sensor. Structural and biochemical analyses estab-
lished that SESN2 can bind and inhibitGATOR2 function under leucine deprivation conditions, and dissociates from
it upon leucine binding [89,90]. Moreover, a recent study revealed that SESN2 expression is induced upon long-term
starvation via the stress-responsive transcription factor ATF4 [91], suggesting a novel role for SESN2 as an indirect
mediator of prolonged amino acid starvation.
Using a similar mechanism, cytosolic arginine activates mTORC1 by directly binding the recently identified argi-
nine sensor CASTOR1 (cellular arginine sensor for mTORC1). This interaction disrupts the CASTOR1–GATOR2
complex, which enables GATOR2 to inactivate GATOR1, thus leading to increased Rag-dependent mTORC1 sig-
nalling [89,92]. These findings establish GATOR2 as a central node in the signalling of both leucine and arginine to
mTORC1, though the molecular function of GATOR2 and the mechanisms through which SESN2 and CASTOR1
regulate it still remain elusive.
Interestingly, although the TSC2/Rheb signalling input has classically been considered to be insensitive to amino
acids [27,93,94], recent studies propose the ability of amino acids to regulate the localization of the TSC complex and
consequently, mTORC1 activity. These findings imply a mechanism via which amino acids can control the activation
of mTORC1 by growth factors [85]. Particularly, arginine suppresses lysosomal localization of the TSC complex and
its interaction with Rheb. By interfering with TSC–Rheb complex, arginine relieves allosteric inhibition of Rheb by
TSC [43]. These findings highlight the cooperation of amino acids with other nutrient inputs (i.e. growth factors) in
the activation of mTORC1.
Themetabolismof glutamine can also activatemTORC1. Specifically, the production ofα-ketoglutarate (α-KG) via
glutaminolysis stimulatesGTP loading of RagB [87]. This process, which takes place inmitochondria, is supported by
leucine availability which acts as a cofactor for the enzyme glutamate dehydrogenase that participates in deamination
of glutamine [87]. The glutaminolysis model provides a sensing mechanism for the activation of mTORC1 by leucine
and glutamine availability.
Amino acid sensing from the plasma membrane
In parallel with the identification of intracellular mediators of amino acid sensing discussed above, other interesting
avenue for this research is focused on finding cell surface molecules involved in the uptake of extracellular amino
acids. Very recently it has been reported that the G-protein coupled taste sensing receptor TIR1/TIR3 is an early sen-
sor of extracellular amino acid availability [95]. Reduced expression levels of TIR1/TIR3 impaired the activation of
mTORC1 by amino acids, caused mislocalization of mTORC1 and accelerated autophagy even under nutrient-rich
conditions [95]. It has been proposed that TIR1/TIR3 activation increases Ca2+ influx, thus activating Erk1/2 [95]
which ultimately activates mTORC1 by phosphorylating Raptor and TSC2. Although the contribution of Erk1/2
phosphorylation to mTORC1 activity via a direct mechanism is still debatable [96], a role for intracellular Ca2+ in
mTORC1 activation has been demonstrated [95,96].
In addition to TIR1/TIR3, a number of solute carriers have been identified as mediators in modulating mTORC1
activity and autophagy, some of them belonging to families capable of transporting amino acids. These amino acid
transporters were initially implicated in mTORC1 regulation as passageways through the plasma membrane, en-
abling amino acids to enter cells and activate cytoplasmic amino acid sensors [50]. Amongst them, the amino acid
transporter, solute carrier family 1, member 5 (SLC1A5) regulates glutamine uptake and loss of its function in-
hibits cell growth and activates autophagy [97]. Another example is the above-mentioned heterodimer SLC7A5
(LAT1)/SLC3A2 which couples import of leucine with export of glutamine [97]. In fact, the glutamine transported
into the cell by SLC1A5 can be used by SLC7A5/SLC3A2 to exchange with leucine, thus increasing intracellular
leucine levels [97]. This could indicate the different impact of individual amino acids on mTORC1 – whilst leucine
directly acts on the mTORC1 pathway glutamine appears to be a facilitator to maximally activate mTORC1. Likewise,
SLC43A1 (LAT3) [98] and SLC38A2 (SNAT2) [99], both transporters of neutral amino acids, have also been linked
to mTORC1 signalling. It is likely that, in addition to specific amino acids, a basal concentration of other amino
acids is also required to activate mTORC1 [43]. Further work is likely to identify the mechanisms that regulate these
amino acid transporters and therefore, contribute to controlling intracellular concentrations of amino acids and sub-
sequently mTORC1. Indeed, the turnover of PAT4, which is regulated by the small GTPase Rab12, can impact on
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modulation of mTORC1 activity and autophagy possibly because its internalization in recycling endosomes (wherein
PAT4 is not functional) consequently reduces the influx and therefore the intracellular levels of amino acids [100].
This observation highlights the trafficking and turnover of amino acid transporters as a mechanism of mTORC1
regulation. It is also possible that a dynamic relationship exists between plasma membrane and intracellular pools of
amino acid transporters, and deciphering themechanisms that regulate this cross-talk will further our understanding
of amino acid sensing by mTORC1.
Amino acid sensing from the Golgi
Two molecules involved in membrane trafficking have been identified as potent regulators of mTORC1. Thus, Arf1,
classically implicated in Golgi transport, has been shown to participate in glutamine-dependent mTORC1 activation
via a Rag-independent lysosomal mechanism in mammalian cells [45]. Additionally, Rab1A, previously known for
its role in vesicle transport between ER and Golgi, is involved in amino acid-dependent mTORC1 activation on the
Golgi, also in a Rag-independent fashion [101]. Specifically, Rab1A interacts withmTORC1 in response to amino acid
sufficiency to promote the colocalization of mTORC1 with Rheb in Golgi [101]. The authors report the preferential
binding of mTORC1 to GTP-bound Rab1A through Raptor, which is increased in the presence of amino acids, and
they also show that the Rab1A–mTORC1 interaction requires the prenylation modification that tethers Rab1A to
the Golgi. These findings place Rab1A, mTOR, Raptor and Rheb at the Golgi following amino acid stimulation.
Knockdown of Rab1A disruptsmTORC1 localization to theGolgi, but not to lysosomes, supporting amodel in which
an mTORC1 hub is assembled on Golgi membranes. Based on these findings and the reported localization of TSC to
the Golgi in addition to lysosomes [102], the authors contend that Rab1A might function in an amino acid sensing
pathway distinct from the classical Rag pathway that either is redundant or senses a different pool of amino acids
or subcellular cues. While lysosomal mTORC1 could detect extracellular or autophagy-derived amino acids in the
lysosomal lumen,Golgi-localizedmTORC1 could be regulated by amino acids trafficked back in a retrogrademanner
from the endosomal system or brought into the Golgi lumen by Golgi-localized amino acid transporters. As a matter
of fact, PAT4 has been shown to be predominantly localized on the trans-Golgi network in several cell types where it
interacts with mTORC1 and Rab1A, to control serine- and glutamine-dependent activation of mTORC1 [101,103].
Clearly more studies are required to clarify how different mechanisms of amino acid sensing at multiple intracellu-
lar compartments are integrated.One exciting possibility is that the intricate network of trafficking pathways between
the Golgi, late endosomes/lysosomes and the plasma membrane allows activated mTORC1 to be transported within
the endomembrane system and to find its substrates [104]. This possibility could explain the mTORC1 sensitivity to
the activity of the regulators of vesicle trafficking such as Rab and Arf GTPases.
Alternative amino acid sensing mechanisms
A number of other pathways have been shown to positively regulate mTORC1 in response to amino acids. Amongst
them, inositol polyphosphate multikinase (IPMK) appears to be a cofactor involved in maintaining the binding of
mTOR with raptor to supress mTORC1 activity upon amino acid deprivation, whereas the presence of amino acids
converts this complex into a low-affinity state thereby allowing lysosomal relocation of mTORC1 for activation [105].
The action of IPMK on amino acid signalling to mTORC1 is independent of its catalytic activity. In addition, the
mitogen-activated protein kinase 3 (MAP4K3) was shown to be required for amino acid-dependent mTORC1 sig-
nalling in both mammalian cells and flies [106,107], though its role in amino acid sensing is not entirely clear.
Another protein recently implicated in the activation of mTORC1 in response to amino acids is the human
class III PI3K (phosphoinositide 3-kinase) hVps34, which catalyses the synthesis of the lipid, phosphatidylinositol
(3)-phosphate (PI(3)P), an important regulator of endocytosis and autophagy. hVps34 is activated by amino acids via
a calcium-dependent mechanism [96] and this leads to an accumulation of PI(3)P in cells, which is believed to cause
the recruitment of proteins to early endosomes, forming an intracellular signalling platform that promotes mTORC1
activation [108,109]. This pathway appears to be vertebrate-specific as studies in flies have reported no observable
effect of this protein on mTORC1 signalling [110].
Additionally, it has been demonstrated that the phosphatidic acid producing enzyme phospholipase D (PLD) is
indispensable for lysosomal translocation and activation of mTORC1 in response of amino acids [111,112]. Specif-
ically, PLD1 has been proposed to be part of the protein complex anchoring mTORC1 to the lysosomal membrane
[112,113].
Finally, in addition to its role on autophagy, the autophagy receptor protein p62 (also known as sequestosome
1, SQSTM1) has recently been identified as an integral part of the mTORC1 complex. p62 interacts in an amino
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acid-dependent manner with TNF receptor associated factor 6 (TRAF6), mTOR and raptor and Rag GTPases to pro-
mote mTORC1 recruitment to lysosomes where it is activated. Specifically, p62 favours the formation of the active
Rag heterodimer and, together with TRAF6 promotes mTORC1 translocation to the lysosome. Via an incompletely
understood mechanism, TRAF6-dependent ubiquitination of mTOR is then required for amino acid-dependent ac-
tivation of mTORC1 [114].
Amino acid/energy sensing and autophagy–lysosome
pathway
Autophagy is a multi-step process in which autophagosomes engulf cytosolic organelles and macromolecules and,
through fusion with lysosomes, target their constituents for degradation [115]. The pathways and molecular mech-
anisms controlling autophagy are well studied. The autophagic machinery is evolutionarily conserved from yeast to
mammals where a set of autophagy-related (Atg) proteins orchestrates distinct stages of the pathway, such as initi-
ation, elongation, maturation and fusion. Autophagy occurs in the cell at a basal level in order to maintain energy
homoeostasis and cellular functions. However, it can be further activated above basal levels in response to many
cellular stressors such as oxygen, energy and nutrient (e.g. amino acid) deprivation [22].
It is now clear that cellular homoeostasis of metabolism and growth is exquisitely controlled by the coordination of
AMPK and mTORC1. AMPK is crucial to the cellular response to low energy levels and, once active, drives processes
which will replenish cellular energy stores, such as autophagy while inhibiting biogenic synthesis [116]. Opposite
to AMPK, activated mTORC1 shifts the metabolic programme of the cell from catabolic to anabolic metabolism by
up-regulating the synthesis of building blocks for cell proliferation, including proteins, lipids and nucleotides [117].
As both mTORC1 and AMPK are essential for the cell to maintain energy and nutrient homoeostasis, it has been
appreciated that their signalling pathways must be coordinated. Several mechanisms of cross-talk have been identi-
fied. Thus, it was shown that AMPK inhibits mTORC1 by activating TSC2 [118-120] or by directly phosphorylating
the mTORC1 component, Raptor on Ser722 and Ser792 [121]. Recent research has also revealed that the lysosome
may function as a crucial hub for integration of signalling in response to both nutrients and energy by reporting the
lysosomal v-ATPase–Ragulator complex as a common activator for AMPK and mTORC1 [122]. The first indication
that AMPKmight have a function on lysosomes was the identification of the interaction of its binding partner, AXIN,
with one of the components of the Ragulator complex, LAMTOR1 [123]. Later studies revealed that AXIN functions
as a scaffold protein for AMPK and its upstream regulator, the liver kinase B1 (LKB1), displaying a weak constitutive
interaction with both AMPK and LKB1 which was found to be enhanced in the presence of AMP or upon glucose
starvation [122]. Specifically, under energy stress, LKB1-bound AXIN translocates to the lysosomal surface wherein
it interacts with the v-ATPase complex and the AMP-bound AMPK. It was also shown that the v-ATPase complex
was required for the enhanced AXIN/LKB1–LAMTOR1 interaction under starvation [122]. The translocation of the
complex LKB1–AXINnot only activates AMPK and turns on catabolic processes, but also turns off anabolic processes
through facilitating starvation-induced lysosomal dissociation and inhibition of mTORC1. These observations sup-
port the role of the v-ATPase–Ragulator complex as a dual sensor for energy/nutrients and posit the lysosome as a
hub coordinating AMPK and mTORC1 signalling [122].
Whereas the role of amino acids as key signal factors in the activation of mTORC1 has been accepted, to date, the
inhibitory effect of amino acids on AMPK has been a debatable issue. Some studies have observed the inhibition of
AMPK by amino acids [124-126], though this has not always been the case [127,128]. A recent work suggests amino
acids as novel metabolic activators of AMPK. In this study, AMPK responded acutely and within 1 min to amino acid
and its activation was independent of mTORC1 [129]. It should be noted that all previous studies observed AMPK
phosphorylation at the earliest at 15 min post amino acid addition. This study explains that, at this time point, AMPK
is repressed and postulates this as the reason why earlier studies may have missed the early AMPK induction by
amino acids. Furthermore, they demonstrate that AMPK activation occurs via the Ca2+/calmodulin-dependent ki-
nase kinase-β (CaMKKβ) and that activation of theCaMKKβ–AMPK axis by amino acids does not inhibit mTORC1
but sustains autophagy. They propose that this sustained autophagy under amino acid sufficiency might be required
to maintain protein homoeostasis and deliver metabolite intermediates for biosynthetic processes [129].
Regulation of autophagy by TORC1 and AMPK signalling is best understood at the stage of autophagosome bio-
genesis. Autophagy pathway is mostly orchestrated by Atg proteins that nucleate distinct complexes, amongst which
ULK1 and Vps34 complexes act as important gatekeepers for autophagy induction [130-134]. The ULK1 complex
consists of three regulatory subunits Atg13, the focal adhesion kinase family interacting protein of 200KDa (FIP200),
Atg101 and the core Ser/Thr kinaseULK1.ULK1 is essential for autophagy induced by amino acid starvation and isdi-
rectly regulated by mTORC1 through phosphorylation at Ser757 [135,136]. The reversible phosphorylation of ULK1
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is a central mechanism by which starvation-induced autophagy is regulated. In amino acid-rich conditions, mTORC1
binds to, phosphorylates and thereby inactivatesULK1 andAtg13, whereas on sensing a decrease in amino acid levels,
mTORC1 dissociates from the ULK1 complex, thus relieving the inhibition of ULK1. Additionally, AMPK coordi-
nates with ULK1 to regulate autophagy. AMPK promotes autophagy by directly phosphorylating several residues in
ULK1 (including Ser555, Ser317 and Ser777, mouseULK1 numbering) which leads to its activation [137-140].Under
nutrient sufficiency, high mTORC1 activity prevents ULK1 activation by phosphorylating ULK1 Ser757 and disrupt-
ing the interaction between ULK1 and AMPK. Interestingly, under starvation, ULK1 can phosphorylate all three
AMPK subunits to down-regulate AMPK activity [141]. This coordinated phosphorylation shows a finely balanced
regulatory signalling network [142].
It has been proposed that amino acid deprivation triggers more rapid autophagy than chemical inhibition of
mTORC1. Indeed, in addition to the inhibition of mTORC1, amino acid starvation causes an increase in the phos-
phatase activity of PP2A towards ULK1 which triggers the rapid dephosphorylation of ULK1 and consequently, ac-
celerates the autophagic response [143]. Specifically, amino acid withdrawal stimulates PP2A activity by inducing its
dissociation from the inhibitory protein α4, which is believed to keep PP2A in an inactive state [143].
Another autophagic complex required for autophagy induction, the Vps34 complex which includes Atg14,
Vps15 and Beclin-1, can be regulated by amino acid sufficiency. Upon amino acid/nutrient abundance, the
mTORC1-dependent phosphorylation of Atg14-containing Vps34 complex inhibits the autophagosome biogenesis
and suppresses autophagy. Conversely, depletion of amino acids causes mTORC1 inhibition, thereby relieving this
pro-autophagy complex to stimulate autophagy [144]. Vps34 contributes to a variety of cellular functions and, as dis-
cussed above, this lipid kinase also participates in amino acid-dependent activation of mTORC1 [108,109]. Vps34
may exist (as in yeast) in two different populations, with and without Beclin-1 association [145].
In addition to autophagic complexes, amino acids also control autophagy through the family of transcriptional
factors regulating autophagic and lysosomal gene expression (Figure 3). The prototypic member of this family is the
transcription factor EB (TFEB) [146,147]. TFEB controls lysosomal biogenesis and autophagy by positively regulating
genes belonging to the CLEAR (coordinated lysosomal expression and regulation) network [148-150]. Thus, TFEB
activation leads to an increased number of autophagosomes and autophagic flux, biogenesis of new lysosomes, and
clearance of storage material [146,149,151,152]. TFEB activity and its nuclear translocation correlate with its phos-
phorylation status [146,153]. Recent studies have reported that Rag GTPases and lysosomal mTORC1 regulate TFEB
localization by phosphorylating the transcription factor on several serine and threonine residues, including Ser211,
under nutrient-rich conditions [147,151]. TFEB phosphorylation on Ser211 facilitates its interaction with the cytoso-
lic chaperone protein 14-3-3which retains (and therefore inactivates) TFEB in the cytoplasm [154].Under amino acid
deprivation,mTORC1 inactivation leads to dephosphorylation and relocalization of TFEB to the nucleuswhere it pro-
motes the expression of lysosomal and autophagy-related genes [146]. This cellular response allows the adaptation to
diminished amino acid levels by increasing lysosomal and autophagic compartments in order to maintain the levels
of energy and metabolites required to survive starvation condition.
Similarly, the transcription factor TFE3, which belongs to the same family that TFEB, is recruited to lysosomes
through direct interaction with active Rags and this recruitment is critical to inactivate TFE3 under nutrient-rich
conditions. Specifically, mTORC1 phosphorylates TFE3 at several residues but Ser321 is particularly relevant as this
phosphorylation creates a binding site for the cytosolic chaperone 14-3-3 which sequestrates this transcription factor
in the cytosol [147,154-157]. The inactivation of Rags andmTORC1 following starvation allows the transport of TFE3
to the nucleus and thus promotes cellular clearance [155]. TFEB and TFE3 are partially redundant in their ability to
induce lysosomal biogenesis in response to nutrient starvation, but both must be present for a maximal response
[155].
Besides the control that mTORC1 exerts on TFEB and TFE3 recruitment, a recent work has reported a feedback
circuit wherein these transcription factors can control lysosomal recruitment of mTORC1 by regulating the expres-
sion of RagD [158]. The fine modulation of this circuit is essential for metabolic adaptation to nutrient availability.
At the same time, the nuclear localization of the transcription factor zinc finger with KRAB and SCAN domains 3
(ZKSCAN3), which acts as a master repressor of lysosomal biogenesis and autophagy in fed cells, is also regulated
by mTORC1 [159]. Overall, the emerging picture reveals the close collaboration between mTORC1 and several other
master regulators of autophagy and lysosomal biogenesis in order to facilitate an efficient response to the varying nu-
trient demands of the cell [156]. As has been described in this section, amino acid starvation up-regulates autophagic
and lysosomal activity through suppression of mTORC1-mediated phosphorylation of ULK1, Atg13, Atg4–Vps34,
TFEB and TFE3 [135,136,139,147,155,156] (Figure 3). However, it has been recently shown that amino acid with-
drawal, besides increased turnover of autophagic cargo, causes selective remodelling of the plasmamembrane in yeast
[160,161]. In this model system, endocytic trafficking of membrane proteins to the vacuole (the yeast equivalent of
c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
575
Essays in Biochemistry (2017) 61 565–584
https://doi.org/10.1042/EBC20170027
Figure 3. Amino acid-dependent regulation of autophagy by mTORC1
Schematic representation of the cellular signalling pathways governed by amino acids in the regulation of autophagy via mTORC1.
Amino acid sufficiency activates the mTORC1 pathway which inhibits autophagy at multiple steps. Although the best-characterized
mechanism via which mTORC1 inhibits autophagy involves the direct control of ULK1, mTORC1 also regulates Atg14-containing
Vps34 complex and TFEB. In amino acid-rich conditions, mTORC1 binds to, phosphorylates and thereby inactivates the autophagy
initiators ULK1 and Atg13, which are present in a complex with FIP200 and Atg101. Likewise, mTORC1 phosphorylates TFEB and
TFE3 and this event facilitates the interaction between TFEB and TFE3 and the cytosolic chaperone 14-3-3 which retains them
in the cytoplasm. In the absence of activating stimuli, autophagy is induced through the dissociation of mTORC1 from the ULK1
complex, thus relieving the inhibition of ULK1 which is then responsible of its own phosphorylation as well as phosphorylation of
Atg13, FIP200 and Raptor. ULK1 is then able to activate this PI3K complex and promote autophagosome synthesis. In addition,
mTORC1 inactivation leads to relocalization of TFEB and TFE3 to the nucleus where they cause the expression of multiple lysosomal
and autophagy-related genes. This allows the cell to maintain a critical level of energy and metabolites for surviving the starvation
condition.
the lysosome) allows their hydrolysis into amino acids which provide material to fuel biosynthesis of more lysosomal
proteins. These newly synthesized lysosomal proteins enhance hydrolysis of a later wave of autophagic cargo [161].
This starvation-induced protein turnover has been proposed to be regulated by TORC1. On one hand, TORC1 sig-
nalling promotes the endocytosis of certain plasmamembrane proteins [162].On the other hand, TORC1 inactivation
triggers endocytosis of other plasmamembrane proteins that are degraded in an endosomal sorting complex required
for transport (ESCRT)-dependent manner via the multivesicular body (MVB) pathway [160,162-165]. Although it
has been proposed that TORC1 signalling controls the major ubiquitin ligase required for endocytosis in yeast, Rsp5,
how TORC1 signalling controls Rsp5-dependent cargo specificity and the selective ubiquitination of many different
cargoes at the same time is currently not clear [161]. Furthermore, how the subsequent ubiquitin-dependent degra-
dation of membrane proteins via the MVB pathway helps to meet the specific metabolic and energetic demands of
the cell during nutrient limitation is not fully understood. The result of starvation-induced up-regulation of endo-
cytosis and vacuolar degradation is a pool of amino acids that is essential for the adaptation to the lack of nutri-
ents. Thus, the MVB pathway helps to maintain translation during acute starvation until autophagy, the long-term
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starvation–response pathway, is fully active.However, is not clear how selective (MVB) and non-selective (autophagy)
lysosomal proteolysis pathways cooperate to mediate cell survival during nutrient limitation.
Autophagy is an important avenue for nutrient supply, particularly during amino acid starvation, which contributes
amino acids to restore mTORC1 activity [166,167]. In turn, autophagy-mediated restoration of mTORC1 induces
autophagy termination and reformation to lysosomes which complete the feedback loop [166]. Although it would be
tempting to envisage that autophagy restores the amino acid pool to reactivate mTORC1, some studies have detected
only a partial restoration of amino acid abundance by autophagy [166,168], which suggests the existence of a more
precise mechanism. Specifically, an increase in the synthesis and release of glutamine during starvation has been
reported. A recent work shows that glutamine is required for autophagy-inducedmTORC1 reactivation during amino
acid starvation and suggests that extracellular glutamine may function as specific starvation-induced nutrient signal
to regulate mTORC1 [169]. In addition, this study demonstrates that the restorative effect of glutamine on mTORC1
signalling requires the conversion of glutamine to glutamate, which in turn sustains the non-essential amino acid
pool via transamination [169].
Challenges and future perspectives
Since amino acids are essential building blocks in the cell, the ability to regulate their levels is fundamental for cell
survival, growth and development. The control of intake, utilization and recycling of amino acids is subjected to a fine
regulation which involves a number of mechanisms that ensure amino acid availability in order to support cellular
function. All these mechanisms integrate amino acid sufficiency with anabolic processes and autophagy. Given the
massive impact of amino acids on autophagy and the importance of autophagy for cell function, the research in the
field of amino acid sensing has expanded exponentially over the last years [170-172]. At the epicentre of amino acid
sensing is the kinase mTORC1 that governs a rapid cellular response to fluctuations in amino acid levels. mTORC1
activity is inhibited upon amino acid withdrawal, which increases flux through autophagy pathway leading to recy-
cling of amino acids and, thereby, restoration ofmTORC1 activity together with the inhibition of autophagy. Thus, the
study of the mechanisms via whichmTORC1 senses amino acid levels has become fundamental to the understanding
of amino acid signalling.
The discovery of the lysosomalRagGTPases as important regulators of amino acid-dependentmTORC1 activation
has focused most of the studies on the identification of molecules that could be involved in amino acid sensing by
modulating the nucleotide state of the Rag GTPases. To date, one of the most relevant has been the characterization
of the v-ATPase, which has led to the prediction that amino acids are sensed within the lysosome [69]. Nonetheless,
besides the well-known role of lysosomes in amino acid sensing, it is now accepted that mTORC1 senses both in-
tralysosomal and cytosolic amino acids through different mechanisms. From the plasma membrane to the cytosol,
novelmolecules directly involved in the sensing of amino acids have recently been revealed. Some examples are IPMK,
MAPK43 or Vps34, which have been proposed as important intracellular proteins in amino acid signalling, although
the mechanisms via which these molecules sense amino acids and activate mTORC1 still remain elusive. An exciting
advance in the field represents the identification of specific cytoplasmic amino acid sensors for some of the most
potent activators of mTORC1, leucine and arginine [90,92,173]. These findings leave open the question of the exis-
tence of additional amino acid sensors in the cytosolwith specificity for other amino acids. Furthermore, intracellular
amino acids exist as free forms or bound to proteins, lipids or other molecules. Future work will be needed to clar-
ify whether the equilibrium between these different pools determine which amino acids are available to the sensors
[172]. One particular aspect that will be of interest is the relative contribution of these different pools of amino acids
in the activation of mTORC1.
An interesting avenue that is expanding in this field is the importance of extracellular amino acids in determining
intracellular amino acid concentrations. This has led to the study of cell surface amino acid transporters since they are
in an ideal location to relay nutritional information, as well as amino acids themselves, to the cell interior. Although
these transporters were initially classified by their ability to translocate specific amino acids across the lipid bilayer,
they have lately emerged as important amino acid sensors controlling mTOR recruitment and activation [73,171].
Indeed, increasing evidence exists suggesting that they can activate amino acid-dependent signalling either in the
presence or absence of transport, by acting as transceptors [171]. This concept of dual-function suggests that part of
the sophisticated control governing the trafficking of amino acids has to do with their signalling function rather than
with the control of transport. Thus, for those amino acid transporters that act as sensors for mTORC1 future work is
likely to unveil whether they directly interact with the amino acids they are believed to sense [171].
As shown by recent studies, amino acid transporters do not function exclusively at the plasmamembrane; they can
also be found intracellularly where theymay increase local concentrations of amino acids. These findings, in addition
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to reinforce the role of lysosome as amino acid storage sites with high concentrations of amino acids at their surface,
open an exciting field of research that predicts that amino acids could be sensed in other subcellular compartments.
Thus, the concentration of amino acidsmay exist in gradients across the intracellular space, specificallywithin various
organelles, and could differ significantly compared with those found in the cytosol since they contain a distinct set of
amino acid transporters [172]. In this multi-hub sensing model, many signalling cascades controlled at a subcellular
level could provide distinct readouts of the cell’smetabolic state and, thereby, the flexibility for amore refined response
within a single cell.
Despite the explosion of knowledge in amino acid sensing in the last years, onemajor unsolved question in this field
revolves around how these novel mechanisms fit with the model of Rag GTPases-dependent amino acid regulation.
Furthermore, how the signals from intracellular nutrients and exogenous growth factors are integrated and what
is the relative role of Rheb and Rag GTPases in this process remain the subject of further investigation [174,175].
Future work is likely to provide more information on the exquisite complexity of the signalling network of amino
acids upstream of mTORC1 to define the exact roles and cooperation of these mechanisms in the tight control of
cellular nutrient response pathways such as autophagy.
Finally, nutrient sensing pathways are of particular socio-economic significance as their perturbation is associated
with the process of ageing and contributes to a number of age-related conditions including cancer, neurodegenera-
tion and cardiovascular disease as highlighted in several reviews in this issue [182,183,184]. Thus, deregulation of
mTORC1 has been described in cellular and organismal senescence where it can remain active even during nutrient
deprivation [176-178]. This could drive uncontrolled growth, hypertrophy and chronic suppression of autophagy, all
potential contributing factors in age-related pathology [179-181]. Further understanding of the molecular mecha-
nisms of mTOR and autophagy and their deregulation in human pathology will facilitate identification of interven-
tions aiming at the extension of healthy lifespan.
Summary
• Amino acids have been elucidated as important regulators of the cell metabolism. As they are es-
sential building blocks in the cells, organisms have developed a number of mechanisms to regulate
their intracellular levels.
• mTORC1 governs the cellular response to fluctuations in amino acid levels, increasing flux through
autophagy pathway when amino acids are scarce in order to generate amino acid sufficiency, in turn
restoring mTORC1 activity and inhibiting autophagy.
• The mechanisms via which amino acids can influence mTORC1 are still partially elucidated demon-
strating the complex control of amino acid sensing. The best-described amino acid sensing pathways
involve the Rag GTPases, although a number of Rag-independent amino acid sensing mechanisms
have recently been identified.
• Increasing evidence suggests that amino acids can signal from both the lysosomal lumen and the
cytoplasm. Although the identification of the complex v-ATPase–Ragulator–Rag GTPase established
the first evidence that amino acid sensing may propagate from within the lysosome (inside–out
model), the recent discovery of cytoplasmic amino acid sensors suggests that some amino acids
can also signal from the cytoplasm.
• Lysosomes, by providing a platform for Rag and Rheb GTPases, create a signalling hub that finely
regulates mTORC1 and AMPK activities and downstream anabolic and catabolic processes including
autophagy.
• Further identification of new molecular players in mTORC1 signalling will undoubtedly expand our
understanding of the exquisite complexity of amino acid signalling upstream of autophagy and their
perturbation in human diseases.
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